Completed OBSERVATIONAL NCT01487057

Lipid Metabolic Status in Thyroid Carcinoma (LITCA)

Evaluation of Lipid Metabolic Status and of Cardiovascular Risk at Patients With Thyroid Carcinoma, Radically Treated and With Chronic Thyroid Hormonal Substitution

Sponsor: Iuliu Hatieganu University of Medicine and Pharmacy

Conditions Dyslipidemias Hormone Replacement Risk Reduction Behavior Thyroid Carcinoma

Updated 6 times since 2017 Last updated: Dec 26, 2012 Started: Feb 28, 2011 Primary completion: Feb 29, 2012 Completion: May 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01487057, this observational or N/A phase trial focuses on Dyslipidemias and Hormone Replacement and remains completed. Sponsored by Iuliu Hatieganu University of Medicine and Pharmacy, it has been updated 6 times since 2011, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None

▶ Show 1 earlier version

Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Feb 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Iuliu Hatieganu University of Medicine and Pharmacy
Prof. Dr. I. Chiricuta Institute of Oncology

Data source: Prof. Dr. I. Chiricuta Institute of Oncology

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cluj-Napoca, Romania